Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-03-26 Option Award | 2024-03-28 4:32 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | HUMPHREY RACHEL Director | 38,741 | $0 | 96,805 (Direct) | View |
2023-03-24 Option Award | 2023-03-28 4:43 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | HUMPHREY RACHEL Director | 58,064 | $0 | 58,064 (Direct) | View |
2022-08-11 Option Award | 2022-08-15 5:44 pm | N/A 2032-08-11 | Pyxis Oncology Inc. | PYXS | HUMPHREY RACHEL Director | 236,220 | $0 | 236,220 (Direct) | View |
Ownership | 2021-10-21 8:41 pm | N/A N/A | Xilio Therapeutics Inc. | XLO | HUMPHREY RACHEL Director | 0 | $0 | 58,133 (Direct) | View |
2021-02-17 Option Award | 2021-02-19 6:55 pm | N/A 2031-02-16 | Black Diamond Therapeutics Inc. | BDTX | HUMPHREY RACHEL Chief Medical Officer | 60,000 | $0 | 60,000 (Direct) | View |
2020-09-08 Option Award | 2020-09-10 4:56 pm | N/A 2030-09-08 | Black Diamond Therapeutics Inc. | BDTX | HUMPHREY RACHEL Chief Medical Officer | 160,000 | $0 | 160,000 (Direct) | View |